Guggenheim analyst Eddie Hickman reiterated a Buy rating on Iveric Bio (NASDAQ: ISEE).The analyst comments "This morning, ISEE announced that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE